Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

1.

Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Parikh SV, LeBlanc SR, Ovanessian MM.

Can J Psychiatry. 2010 Mar;55(3):136-43.

PMID:
20370963
[PubMed - indexed for MEDLINE]
2.

Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.

Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS.

Am J Psychiatry. 2006 Feb;163(2):210-6.

PMID:
16449473
[PubMed - indexed for MEDLINE]
3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
4.

Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD).

Bowden CL, Perlis RH, Thase ME, Ketter TA, Ostacher MM, Calabrese JR, Reilly-Harrington NA, Gonzalez JM, Singh V, Nierenberg AA, Sachs GS.

CNS Neurosci Ther. 2012 Mar;18(3):243-9. doi: 10.1111/j.1755-5949.2011.00257.x. Epub 2011 Jun 7. Review.

PMID:
22070541
[PubMed - indexed for MEDLINE]
5.

Treatments for late-life bipolar disorder.

Aziz R, Lorberg B, Tampi RR.

Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. Review.

PMID:
17296540
[PubMed - indexed for MEDLINE]
6.

Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.

Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH; STEP-BD Investigators.

J Clin Psychopharmacol. 2004 Oct;24(5):512-20.

PMID:
15349007
[PubMed - indexed for MEDLINE]
7.

Illness course, comorbidity, gender, and suicidality in patients with bipolar disorder.

Baldassano CF.

J Clin Psychiatry. 2006;67 Suppl 11:8-11. Review.

PMID:
17029490
[PubMed - indexed for MEDLINE]
8.

Effectiveness of lamotrigine in bipolar disorder in a clinical setting.

Ketter TA, Brooks JO, Hoblyn JC, Champion LM, Nam JY, Culver JL, Marsh WK, Bonner JC.

J Psychiatr Res. 2008 Nov;43(1):13-23. doi: 10.1016/j.jpsychires.2008.02.007.

PMID:
18423667
[PubMed - indexed for MEDLINE]
9.

Lessons from STEP-BD for the treatment of bipolar depression.

Nierenberg AA.

Depress Anxiety. 2009;26(2):106-9. doi: 10.1002/da.20547. No abstract available.

PMID:
19177467
[PubMed - indexed for MEDLINE]
10.

Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, Sachs GS, Nierenberg AA, Thase ME, Pollack MH.

Am J Psychiatry. 2004 Dec;161(12):2222-9.

PMID:
15569893
[PubMed - indexed for MEDLINE]
11.

Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials.

Singh JB, Zarate CA Jr.

Bipolar Disord. 2006 Dec;8(6):696-709. Review.

PMID:
17156156
[PubMed - indexed for MEDLINE]
12.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.

Beaulieu S, Saury S, Sareen J, Tremblay J, Sch├╝tz CG, McIntyre RS, Schaffer A; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):38-55. Review.

PMID:
22303521
[PubMed - indexed for MEDLINE]
13.

Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME.

Am J Psychiatry. 2006 Feb;163(2):217-24.

PMID:
16449474
[PubMed - indexed for MEDLINE]
14.

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).

Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, Lavori P, Lebowitz B, Rudorfer M, Frank E, Nierenberg AA, Fava M, Bowden C, Ketter T, Marangell L, Calabrese J, Kupfer D, Rosenbaum JF.

Biol Psychiatry. 2003 Jun 1;53(11):1028-42. Review.

PMID:
12788248
[PubMed - indexed for MEDLINE]
15.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
[PubMed - indexed for MEDLINE]
16.

Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.

Smith LA, Cornelius V, Warnock A, Bell A, Young AH.

Bipolar Disord. 2007 Jun;9(4):394-412. Review.

PMID:
17547586
[PubMed - indexed for MEDLINE]
17.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
[PubMed - indexed for MEDLINE]
18.

Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).

Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, Bowden CL, Sachs GS, Nierenberg AA; STEP-BD Investigators.

Biol Psychiatry. 2004 May 1;55(9):875-81.

PMID:
15110730
[PubMed - indexed for MEDLINE]
19.

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.

Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young LT, Ravindran A, Schaffer A, Connolly M, Gorman CP; Canadian Network for Mood and Anxiety Treatments.

Bipolar Disord. 2005;7 Suppl 3:5-69. Review.

PMID:
15952957
[PubMed - indexed for MEDLINE]
20.

Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.

van der Loos ML, Mulder P, Hartong EG, Blom MB, Vergouwen AC, van Noorden MS, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

Bipolar Disord. 2011 Feb;13(1):111-7. doi: 10.1111/j.1399-5618.2011.00887.x.

PMID:
21320258
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk